Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Rhumbline Advisers
Rhumbline Advisers lifted its position in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 7.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,189 shares of the company’s stock after acquiring an additional 4,600 shares during the period. Rhumbline Advisers’ holdings […]
